Pharmacotherapy of scleritis: current paradigms and future directions

• Published in: Expert opinion on pharmacotherapy Vol. 14; no. 4; p. 411
• Main Authors: Beardsley, Robert M, Suhler, Eric B, Rosenbaum, James T, Lin, Phoebe
• Format: Journal Article
• Language: English
• Published: England 01.03.2013
• Subjects: Adrenal Cortex Hormones - administration & dosage; Adrenal Cortex Hormones - adverse effects; Adrenal Cortex Hormones - therapeutic use; Anti-Bacterial Agents - administration & dosage; Anti-Bacterial Agents - adverse effects; Anti-Bacterial Agents - therapeutic use; Anti-Inflammatory Agents, Non-Steroidal - administration & dosage; Anti-Inflammatory Agents, Non-Steroidal - adverse effects; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use; Humans; Immunosuppressive Agents - administration & dosage; Immunosuppressive Agents - adverse effects; Immunosuppressive Agents - therapeutic use; Practice Guidelines as Topic; Scleritis - drug therapy; Scleritis - etiology; Scleritis - immunology; Treatment Outcome

Scleritis is an inflammatory condition affecting the eye wall that may be associated with a number of systemic inflammatory diseases. Because scleritis can be refractory to standard treatment, knowledge of the body of available and emerging therapies is paramount and is reviewed here. This review fo...